|
August 2004 |
Even with the development of new imaging technology, fluorescein angiography remains a valuable tool for diagnosing and treating AMD.
Indocyanine green angiography comes into its own as a tool for AMD diagnosis and management.
Where does optical coherence tomography fit into AMD treatment decision-making and outcomes assessment? A clinical investigator weighs in.
Understanding a patient's perception of his quality of life may play an important role in evaluating AMD treatment options.